List view / Grid view
The regulator’s new principles aim to ease the pathway to…
The regulator’s new principles aim to ease the pathway to regulatory approval for rare disease drug developers in the US.
US regulator says the move to open up the FAERS…
US regulator says the move to open up the FAERS database will help modernise its safety monitoring.
The pharma company will add to its existing Chicago site,…
The pharma company will add to its existing Chicago site, boosting its active pharmaceutical ingredient production capacity.
CBER head makes surprise comeback just weeks after his abrupt…
CBER head makes surprise comeback just weeks after his abrupt resignation.
The scheme will provide more support and a streamlined application…
The scheme will provide more support and a streamlined application process to companies constructing new US facilities.
